mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
7e-05 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
7e-05 |
mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
8e-05 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
9e-05 |
mRNA |
piperlongumine |
GDSC1000 |
pan-cancer |
AAC |
-0.16 |
9e-05 |
mRNA |
AZD6244 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.0001 |
mRNA |
FK866 |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
0.0002 |
mRNA |
WZ4002 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
0.0002 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.0003 |
mRNA |
S-Trityl-L-cysteine |
FIMM |
pan-cancer |
AAC |
-0.56 |
0.0005 |